US Stock MarketDetailed Quotes
KAPA Kairos Pharma
- 2.054
- +0.694+51.05%
Close Nov 12 16:00 ET
- 2.530
- +0.476+23.16%
Post 19:17 ET
26.38MMarket Cap-11412P/E (TTM)
2.210High1.370Low1.44MVolume1.400Open1.360Pre Close2.93MTurnover92.68%Turnover RatioLossP/E (Static)12.84MShares4.00052wk High-29.77P/B3.18MFloat Cap1.22052wk Low--Dividend TTM1.55MShs Float4.000Historical High--Div YieldTTM61.77%Amplitude1.220Historical Low2.039Avg Price1Lot Size
About Kairos Pharma Company
Kairos Pharma Ltd. is a clinical-stage biopharmaceutical company, which engages in the development of novel and transformative drug therapies to treat cancer. It focuses on the research and development of immunotherapies for oncology. The company was founded by John S. Yu on June 17, 2013 and is headquartered in Los Angeles, CA.
Company Profile
SymbolKAPA
Company NameKairos Pharma
Listing DateSep 16, 2024
Founded2013
CEODr. John S. Yu,M.D.
MarketAMEX
Employees3
Fiscal Year Ends12-31
Address2355 Westwood Boulevard,Suite 139
CityLos Angeles
ProvinceCalifornia
CountryUnited States of America
Zip Code90064
Phone1-310-948-2356
Websitehttp://kairospharma.com
Company Executives
- Name
- Position
- Salary
- Dr. John S. Yu,M.D.
- Chairman of the Board and Chief Executive Officer
- --
- Neil Bhowmick
- Chief Scientific Officer
- --
- Doug Samuelson
- Chief Financial Officer
- --
- Ramachandran Murali, PhD
- Vice President of Research and Development
- --
- Hyun W. Bae, M.D.
- Independent Director
- --
- Dr. Rosemary Mazanet, M.D.,PhD
- Independent Director
- --
- Dr. Hansoo Michael Keyoung, M.D.,PhD
- Independent Director
- --
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data
